Previous Close | 0.4000 |
Open | 0.6600 |
Bid | 0.0000 |
Ask | 2.7000 |
Strike | 1.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.4000 - 0.6600 |
Contract Range | N/A |
Volume | |
Open Interest | 51 |
VIENNA, Va., May 16, 2024--CEL-SCI Corporation reports second quarter fiscal 2024 financial results.
VIENNA, Va., May 08, 2024--CEL-SCI receives FDA go-ahead for its confirmatory study of Multikine in the treatment of head & neck cancer.
VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.